Beta Bionics announced that it appointed Dr. Steven Russell as its chief medical officer (CMO) as it readies itself for a major product launch.
Concord, Massachusetts-based Beta Bionics develops the iLet bionic pancreas system. The pocket-sized, wearable, investigational iLet device autonomously doses insulin. Worn like an insulin pump, iLet users only enter body weight to initialize therapy. Users would no longer have the need for insulin regimen parameters.
The company designed the device to then automatically titrate and infuse insulin. It eliminates the requirement of counting carbs, the settings of certain rates and factors and more.
Get the full story at our sister site, Drug Delivery Business News.